AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

NEBIVOLOL HCL

10 registrations across 3 African markets— 8 active

Markets with NEBIVOLOL HCL

Recent registrations

Brand / ProductMarketHolderStatusExpires
NEBIEM 5
Tablet Uncoated
🇿🇲ZambiaMSN Laboratories Private LimitedactiveMay 2031
Nebiem 10
Uncoated Tablet
🇿🇲ZambiaMSN Laboratories Private LimitedactiveMay 2031
Nodon 5 tablets
Tablet Uncoated
🇿🇲ZambiaCadila Pharmaceuticals LimitedactiveMay 2029
Nebilong tablets
Tablet Uncoated
🇿🇲ZambiaMICRO LABS LTDactiveMay 2029
NEBILONG_10 10MG TABLET
TABLET
🇲🇼MalawiexpiredMar 2025
NEBILOC-5 5MG TABLET
TABLET
🇲🇼MalawiexpiredJun 2015
NEBIVOLOL HCL
ORAL SOLID ORDINARY TABLETS
🇺🇬UgandaMICRO LABS LTDactive
NEBIVOLOL HCL
ORAL SOLID ORDINARY TABLETS
🇺🇬UgandaMICRO LABS LTDactive
NEBIVOLOL HCL
ORAL SOLID ORDINARY TABLETS
🇺🇬UgandaMICRO LABS LTDactive
NEBIVOLOL HCL
ORAL SOLID ORDINARY TABLETS
🇺🇬UgandaMICRO LABS LTDactive

NEBIVOLOL HCL in Africa — Regulatory Overview

NEBIVOLOL HCL is registered across 3 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Uganda, Zambia, Malawi. AfricaRegulatory refreshes this data daily from official government sources.

Of the 10 registrations, 8 (80%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.